US4183936A
(en)
*
|
1972-06-19 |
1980-01-15 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzheterocycles
|
US4115577A
(en)
*
|
1972-06-19 |
1978-09-19 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzheterocycles
|
US4013652A
(en)
*
|
1972-06-19 |
1977-03-22 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzoxazine
|
CH644602A5
(de)
*
|
1978-06-05 |
1984-08-15 |
Sankyo Co |
Benzothiazocin- und benzothiazoninderivate, ihre herstellung und diese derivate enthaltende pharmazeutische praeparate.
|
US4219550A
(en)
*
|
1978-11-09 |
1980-08-26 |
E. I. Du Pont De Nemours And Company |
Cis- and trans- octahydropyridopyrrolobenzheterocycles
|
US4997831A
(en)
*
|
1988-09-01 |
1991-03-05 |
Glaxo Group Limited |
Lactam derivatives
|
US5223625A
(en)
*
|
1988-12-22 |
1993-06-29 |
Duphar International Research B.V. |
Annelated indolo [3,2,-C]lactams
|
EP0380155A1
(en)
*
|
1989-01-19 |
1990-08-01 |
Duphar International Research B.V |
8,9-Annelated-1,2,3,4-tetrahydro-beta-carboline derivatives
|
US7071186B2
(en)
|
1999-06-15 |
2006-07-04 |
Bristol-Myers Squibb Pharma Co. |
Substituted heterocycle fused gamma-carbolines
|
US6713471B1
(en)
|
1999-06-15 |
2004-03-30 |
Bristol-Myers Squibb Pharma Company |
Substituted heterocycle fused gamma-carbolines
|
WO2000077010A2
(en)
|
1999-06-15 |
2000-12-21 |
Du Pont Pharmaceuticals Company |
Substituted heterocycle fused gamma-carbolines
|
HUP0303432A3
(en)
*
|
2000-12-20 |
2012-09-28 |
Bristol Myers Squibb Co |
Substituted pyridoindoles as serotonin agonists and antagonists and pharmaceutical compositions containing the compounds and their use
|
US6849619B2
(en)
*
|
2000-12-20 |
2005-02-01 |
Bristol-Myers Squibb Company |
Substituted pyridoindoles as serotonin agonists and antagonists
|
RU2003121306A
(ru)
|
2000-12-20 |
2005-03-10 |
Бристол-Маерс Сквибб Компани (Us) Бристол-Маерс Сквибб Компани (Us) |
Замещенные пирролохинолины и пиридохинолины в качестве агонистов и антагонистов серотонина
|
CA2431970A1
(en)
|
2000-12-20 |
2002-08-01 |
Bristol-Myers Squibb Pharma Company |
Substituted pyrazinoquinoxaline derivatives as serotonin receptor agonists and antagonists
|
MXPA04002615A
(es)
|
2001-09-21 |
2004-07-08 |
Upjohn Co |
Compuestos del ligando 5-ht terapeuticos.
|
ES2364046T3
(es)
*
|
2002-12-19 |
2011-08-23 |
Bristol-Myers Squibb Company |
Gamma-carbolinas tricíclicas sustituidas utilizadas como agonistas y antagonistas de los receptores de la serotonina.
|
AU2008226814C1
(en)
|
2007-03-12 |
2014-11-20 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycle fused gamma-carbolines synthesis
|
US8575186B2
(en)
|
2009-10-05 |
2013-11-05 |
Albany Molecular Research, Inc. |
Epiminocycloalkyl[b] indole derivatives as serotonin sub-type 6 (5-HT6) modulators and uses thereof
|
US9067949B2
(en)
|
2011-01-19 |
2015-06-30 |
Albany Molecular Research, Inc. |
Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-HT6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia
|
JP6334511B2
(ja)
|
2012-04-14 |
2018-05-30 |
イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. |
新規方法
|
PT2968320T
(pt)
|
2013-03-15 |
2021-01-28 |
Intra Cellular Therapies Inc |
Compostos orgânicos
|
JP6475727B2
(ja)
|
2013-12-03 |
2019-02-27 |
イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. |
新規方法
|
US9745300B2
(en)
|
2014-04-04 |
2017-08-29 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
MX2021014508A
(es)
|
2014-04-04 |
2023-05-18 |
Intra Cellular Therapies Inc |
Gamma-carbolinas fusionadas con heterociclos sustituidas con deuterio.
|
PL3838274T3
(pl)
|
2016-01-26 |
2024-04-02 |
Intra-Cellular Therapies, Inc. |
Pochodna pirydo[3',4':4,5]pirolo[1,2,3-DE]chinoksaliny do zastosowania w leczeniu zaburzeń OUN
|
IL281050B2
(en)
|
2016-03-25 |
2023-04-01 |
Intra Cellular Therapies Inc |
A controlled or delayed release pharmaceutical preparation containing a deuterated compound
|
US11014925B2
(en)
|
2016-03-28 |
2021-05-25 |
Intra-Cellular Therapies, Inc. |
Co-crystals of 1-(4-fluoro-phenyl)-4-((6bR,1OaS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H- pyrido[3′,4′:4,51_pyrrolo [1,2,3-delqcuinoxalin-8-yl)-butan-1-one with nicotinamide or isonicotinamide
|
EP3436083A4
(en)
|
2016-03-28 |
2019-11-27 |
Intra-Cellular Therapies, Inc. |
NOVEL COMPOSITIONS AND METHOD
|
US10654854B2
(en)
|
2016-03-28 |
2020-05-19 |
Intra-Cellular Therapies, Inc. |
Salts and crystals of ITI-007
|
CN110072518B
(zh)
|
2016-10-12 |
2021-10-26 |
细胞内治疗公司 |
无定形固体分散体
|
US10961245B2
(en)
|
2016-12-29 |
2021-03-30 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycle fused gamma-carbolines for treatment of central nervous system disorders
|
WO2018126143A1
(en)
|
2016-12-29 |
2018-07-05 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
CN116327770A
(zh)
|
2017-03-24 |
2023-06-27 |
细胞内治疗公司 |
新组合物和方法
|
US11427587B2
(en)
|
2017-07-26 |
2022-08-30 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
CN111093665A
(zh)
|
2017-07-26 |
2020-05-01 |
细胞内治疗公司 |
有机化合物
|
BR112020019119A2
(pt)
|
2018-03-23 |
2021-01-12 |
Intra-Cellular Therapies, Inc. |
Compostos orgânicos
|
EP3628007B1
(en)
|
2018-06-06 |
2023-05-03 |
Intra-Cellular Therapies, Inc. |
Novel salts and crystals
|
ES3028377T3
(en)
|
2018-06-08 |
2025-06-19 |
Intra Cellular Therapies Inc |
Fused gamma-carbolines for acute treatment of anxiety or depression
|
WO2019241278A1
(en)
|
2018-06-11 |
2019-12-19 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycle fused gamma-carbolines synthesis
|
WO2020047241A1
(en)
|
2018-08-29 |
2020-03-05 |
Intra-Cellular Therapies, Inc. |
Novel compositions and methods
|
KR20210052471A
(ko)
|
2018-08-31 |
2021-05-10 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
신규한 방법
|
BR112021003838A2
(pt)
|
2018-08-31 |
2021-05-18 |
Intra-Cellular Therapies, Inc. |
métodos novos
|
KR20220029744A
(ko)
|
2019-07-07 |
2022-03-08 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
신규 방법
|